While we’re learning more about how the present terpenes in a strain might play a more important role in the effect or ‘high’, consumers actually consider their options in a simple way: “get the highest THC for lowest $.
Approximately 36 states and 4 territories have enacted measures in the medical marijuana industry and recreational can’t be far behind… consumer demand is playing its part in shaping the successful product lines and brands.
The product suite is comprised of cosmetic products and offers skin care benefits, using the unique beneficial properties of cannabis derived oil.
The products are medically authorized in three additional Latin American countries through the Colombian registration, opening the door for future product recognition and registration in the participating member countries of the Andean Pact, which includes Bolivia, Colombia, Ecuador and Peru.
EIC currently holds a Research License and a Standard Processing License issued under the Cannabis Act and regulations; it is in the process in of completing its application to add the activity of sale of Cannabis 2.0 products to its Standard Processing License.
, a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, recently announced the launch of Cann, a leading cannabis-infused beverage brand, in Illinois.
Adding Solevo to our production and dispensary permits, as well as our recently announced definitive agreement to acquire Mountaineer Holdings and its cultivation and dispensary permits, will create a fully vertical presence in the state with nine dispensaries,” said Kim Rivers, CEO of Trulieve.
recently announced the opening of its Emeryville location in California as it continues to expand its market leading presence in the world’s largest cannabis market.
Our premium flower strains include classics such as Jack Herer, and Pineapple Express, as well as exotics like Runtz and Lemon Cherry Gelato.
You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.